DC 7900Endocrine
Hyperthyroidism Including But Not Limited To Graves Disease
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
100% free · no login required
Conditions
746 Part 4 diagnostic code rows—search by code, name, or category. Each row opens rating criteria, effective-date guidance, and claim notes.
Educational summaries last verified against eCFR Part 4: April 2, 2026
Diagnostic-code catalog
PACT Act presumptive conditions
These are general research lists, not eligibility results. Burn-pit and Agent Orange presumptions have different qualifying service rules. VA must verify the applicable location and dates, exposure rules, and a current diagnosis before applying a presumption to an individual claim.
Gulf War era and post-9/11 burn-pit presumptives
VA presumes toxic exposure for service in listed locations during covered dates. A listed diagnosis may qualify when the service and condition requirements are met.
The PACT Act expanded presumptions for specified respiratory conditions and cancers. VA still verifies that the diagnosis and the veteran's location, dates, and character of service meet the applicable requirements.
Asthma (diagnosed after service)
DC 660238 U.S.C. § 1120(b) / 38 CFR § 3.320
PACT Act §406 — must be diagnosed after service.
Chronic bronchitis
DC 660038 U.S.C. § 1120(b)
PACT Act §406.
Chronic obstructive pulmonary disease (COPD)
DC 660438 U.S.C. § 1120(b)
PACT Act §406.
Constrictive bronchiolitis or obliterative bronchiolitis
DC 682538 U.S.C. § 1120(b)
Listed by VA for qualifying Gulf War era and post-9/11 service.
Chronic rhinitis
DC 652238 U.S.C. § 1120(b)
PACT Act §406.
Chronic sinusitis
DC 651338 U.S.C. § 1120(b)
PACT Act §406.
Emphysema
DC 660338 U.S.C. § 1120(b)
PACT Act §406.
Granulomatous disease
38 U.S.C. § 1120(b)
PACT Act §406 — specific diagnostic code depends on the diagnosed disease.
Interstitial lung disease
DC 682538 U.S.C. § 1120(b)
PACT Act §406.
Pleuritis
DC 684538 U.S.C. § 1120(b)
PACT Act §406.
Pulmonary fibrosis
DC 682538 U.S.C. § 1120(b)
PACT Act §406.
Sarcoidosis
DC 684638 U.S.C. § 1120(b)
PACT Act §406.
Respiratory cancer of any type
DC 681938 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed cancer.
Head cancer of any type
38 U.S.C. § 1120(b)
PACT Act §406 — condition family, DC assigned per specific cancer.
Neck cancer of any type
38 U.S.C. § 1120(b)
PACT Act §406 — condition family.
Gastrointestinal cancer of any type
38 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed cancer.
Reproductive cancer of any type
38 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed cancer.
Kidney cancer
38 U.S.C. § 1120(b)
PACT Act §406.
Brain cancer
38 U.S.C. § 1120(b)
PACT Act §406.
Glioblastoma
38 U.S.C. § 1120(b)
PACT Act §406.
Pancreatic cancer
38 U.S.C. § 1120(b)
PACT Act §406.
Melanoma
38 U.S.C. § 1120(b)
PACT Act §406.
Lymphoma of any type
38 U.S.C. § 1120(b)
Condition family; the diagnostic code depends on the diagnosed lymphoma.
Source reviewed 2026-08-22. Check this group’s current VA requirements.
PACT Act additions to the Agent Orange presumptive list
The PACT Act added hypertension and monoclonal gammopathy of undetermined significance (MGUS) to VA’s Agent Orange presumptive-condition list.
These are herbicide-exposure presumptions, not burn-pit presumptions. VA verifies a recognized Agent Orange exposure location and dates plus a current diagnosis.
Hypertension
DC 710138 CFR § 3.309(e)
PACT Act addition to the Agent Orange presumptive-condition list.
Monoclonal gammopathy of undetermined significance (MGUS)
38 CFR § 3.309(e)
PACT Act addition to the Agent Orange presumptive-condition list.
Source reviewed 2026-08-22. Check this group’s current VA requirements.
Conditions are researched individually; there is no bulk-add action.
Showing 18 of 19 matching entries in Endocrine
38 CFR § 4.119
DC 7901Endocrine
Thyroid Enlargement Toxic
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7902Endocrine
Thyroid Enlargement Nontoxic
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7903Endocrine
Hypothyroidism
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7904Endocrine
Hyperparathyroidism
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7905Endocrine
Hypoparathyroidism
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7906Endocrine
Thyroiditis
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7907Endocrine
Cushing S Syndrome
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7908Endocrine
Acromegaly
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7909Endocrine
Diabetes Insipidus
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7911Endocrine
Addison S Disease Adrenocortical Insufficiency
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7912Endocrine
Polyglandular Syndrome Multiple Endocrine Neoplasia Autoimmune Polyglandular Syndrome
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7913Endocrine
Diabetes Mellitus
Rated based on insulin requirements and complications.
DC 7914Endocrine
Malignant Neoplasm
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7915Endocrine
Benign Neoplasm
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7916Endocrine
Hyperpituitarism
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7917Endocrine
Hyperaldosteronism
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
DC 7918Endocrine
Pheochromocytoma
Educational index row from the rating schedule naming convention; confirm exact diagnostic code, effective date, and criteria in the current eCFR Part 4.
Reviewed starting points
Commonly researched conditions
These links are starting points, not recommendations about what anyone should claim.
Disclaimer: Confirm every code and percentage in the current eCFR Part 4. This index is for education only.
⚠️ Important Disclaimer
This page provides general educational information based on public VA regulations and VA.gov resources. It is not legal or medical advice, and My Claim Packet is not a VA-accredited representative. Any worksheets or draft documents produced by the tools must be reviewed for accuracy and are not filed with VA for you. Ratings and service connection are decided case-by-case from the individual record. Consult a VA-accredited VSO, claims agent, attorney, or qualified clinician for help with your situation, and verify current rules using the linked official source.